CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Amino Acids

• Publication date

  2006-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00726-006-0334-xPMID 16738800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.

  2006cited by this paper
• Regional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats.

  2006cited by this paper
• Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor

  2006influential reference
• Cholecystokinin-2 (CCK2) receptor-mediated anxiety-like behaviors in rats.

  2005influential reference
• Association study of 90 candidate gene polymorphisms in panic disorder

  2005cited by this paper
• Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A Receptor

  2005cited by this paper
• Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior.

  2005influential reference
• Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.

  2005cited by this paper
• Effects of Altered Amygdalar Neuropeptide Y Expression on Anxiety-Related Behaviors

  2005cited by this paper
• Involvement of Cholecystokininergic Systems in Anxiety-Induced Hyperalgesia in Male Rats: Behavioral and Biochemical Studies

  2005cited by this paper
• Anxiogenic Effect of Cholecystokinin in the Dorsal Periaqueductal Gray

  2004cited by this paper
• Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

  2004cited by this paper
• Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.

  2004cited by this paper
• Brain neuropeptide Y (NPY) system: a candidate target for treatment of anxiety, depression and alcohol dependence

  2004influential reference
• Molecular evolution of NPY receptor subtypes.

  2004cited by this paper
• Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder.

  2004cited by this paper
• Neuropeptide Y Inhibits Hypocretin/Orexin Neurons by Multiple Presynaptic and Postsynaptic Mechanisms: Tonic Depression of the Hypothalamic Arousal System

  2004cited by this paper
• Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

  2004cited by this paper
• The NPY system in stress, anxiety and depression.

  2004influential reference
• Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.

  2004cited by this paper
• Cholecystokinin-B receptor gene expression in cerebellum, pre-frontal cortex and cingulate gyrus and its association with suicide.

  2004cited by this paper
• Interactions between NPY and CRF in the amygdala to regulate emotionality.

  2004cited by this paper
• Neuroanatomical and pharmacological evidence for a functional interaction between GABAergic and NPY-Y1 transmission in the amygdala of Y1R/LacZ transgenic mice.

  2004cited by this paper
• Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats.

  2004cited by this paper
• Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation

  2004influential reference
• New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454

  2004cited by this paper
• Future of Neuropeptides in Biological Psychiatry and Emotional Psychopharmacology: Goals and Strategies

  2004cited by this paper
• Cholecystokinin and panic disorder

  2004cited by this paper
• Identification of a series of CCK-2 receptor nonpeptide agonists: Sensitivity to stereochemistry and a receptor point mutation

  2003cited by this paper
• Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity.

  2003cited by this paper
• Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors

  2003cited by this paper
• Involvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory.

  2003cited by this paper
• Genetic variations in CCK2 receptor in PVG hooded and Sprague-Dawley rats and its mRNA expression on cat exposure.

  2003cited by this paper
• Pentagastrin test for anxiety – psychophysiology and personality

  2003cited by this paper
• Textbook of Biological Psychiatry

  2003cited by this paper
• Changes in brain cholecystokinin and anxiety-like behavior following exposure of mice to predator odor.

  2003cited by this paper
• Altered Hippocampal Expression of Neuropeptides in Seizure‐prone GALR1 Knockout Mice

  2003cited by this paper
• Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice.

  2003cited by this paper
• Different data from different labs: lessons from studies of gene-environment interaction.

  2003cited by this paper
• Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.

  2003influential reference
• SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI

  2002cited by this paper
• The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.

  2002cited by this paper
• Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.

  2002cited by this paper
• Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive.

  2002cited by this paper
• Area postrema lesions elevate NPY levels and decrease anxiety-related behavior in rats.

  2002cited by this paper
• Decreased CCKB receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior

  2002cited by this paper
• Neuropeptide Y (NPY) and depression: from animal studies to the human condition.

  2002cited by this paper
• Behavioral Profile of CCK2 Receptor-deficient Mice

  2001cited by this paper
• Enhanced Cortical Extracellular Levels of Cholecystokinin-Like Material in a Model of Anticipation of Social Defeat in the Rat

  2001cited by this paper
• Neuropeptide Y Y1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety.

  2001cited by this paper
• Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine.

  2001cited by this paper
• Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus.

  2001cited by this paper
• Leptin decreases feeding and exploratory behaviour via interactions with CCK(1) receptors in the rat.

  2001cited by this paper
• Strain differences in freezing behavior of PVG hooded and Sprague–Dawley rats: differential cortical expression of cholecystokinin2 receptors

  2001cited by this paper
• A Cholecystokinin-Mediated Pathway to the Paraventricular Thalamus Is Recruited in Chronically Stressed Rats and Regulates Hypothalamic-Pituitary-Adrenal Function

  2000cited by this paper
• Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat

  2000cited by this paper
• Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.

  2000influential reference
• Neuropeptides--an overview.

  2000cited by this paper
• Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP-4 treatment on social behaviour in the rat.

  2000cited by this paper
• Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304.

  2000cited by this paper
• Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.

  2000influential reference
• Priming pattern determines the correlation between hippocampal theta activity and locomotor stepping elicited by stimulation in anesthetized rats.

  2000cited by this paper
• Chapter IX Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains

  2000cited by this paper
• Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment.

  1999cited by this paper
• Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain

  1999cited by this paper
• Alterations of corticotropin releasing hormone (CRH) and neuropeptide Y (NPY) plasma levels in mood disorder patients with a recent suicide attempt.

  1999cited by this paper
• Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test.

  1999cited by this paper
• Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.

  1999cited by this paper
• Regulation of Neuropeptide Y Release by Neuropeptide Y Receptor Ligands and Calcium Channel Antagonists in Hypothalamic Slices

  1999cited by this paper
• Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex

  1999cited by this paper
• Regulation of CCK mRNA expression in the rat brain by stress and treatment with sertraline, a selective serotonin re-uptake inhibitor.

  1999cited by this paper
• Neuropeptide Y Y1 receptor antagonist BIBP3226 produces conditioned place aversion in rats.

  1999cited by this paper
• Anxiogenic effect of central CCK administration is attenuated by chronic fluoxetine or ipsapirone treatment.

  1999cited by this paper
• Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

  1999influential reference
• Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat.

  1999cited by this paper
• Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress.

  1999cited by this paper
• Typology of common psychiatric syndromes

  1998cited by this paper
• Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress.

  1998cited by this paper
• NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test

  1998cited by this paper
• Affective Neuroscience: The Foundations of Human and Animal Emotions

  1998cited by this paper
• Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour.

  1998cited by this paper
• Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.

  1998cited by this paper
• Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes.

  1998cited by this paper
• Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats.

  1998cited by this paper
• Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1‐selective antagonist BIBP3226

  1998cited by this paper
• Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.

  1998cited by this paper
• Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.

  1997cited by this paper
• Anxiolytic activity of NPY receptor agonists in the conflict test

  1997cited by this paper
• Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.

  1997cited by this paper
• The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.

  1997cited by this paper
• Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.

  1997cited by this paper
• Activation of Amygdala CholecystokininB Receptors Potentiates the Acoustic Startle Response in the Rat

  1997cited by this paper
• Blockade of CCKB but not CCKA receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: Implications for anxiety associated with posttraumatic stress disorder.

  1997cited by this paper
• The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

  1997cited by this paper
• The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze.

  1996cited by this paper
• Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice

  1996cited by this paper
• CCK‐4‐Induced Calcium Mobilization in T Cells Is Enhanced in Panic Disorder

  1996cited by this paper
• Cholecystokinin peptides and receptors in the rat brain during stress

  1996cited by this paper
• Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.

  1996cited by this paper
• Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.

  1995cited by this paper

• Antidepressant‐ and Anxiolytic‐Like Effect of the Froriepia subpinnata Extract in the Rat: Neurochemical Correlates

  2024cites this paper
• Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons.

  2023cites this paper
• Social Fear Affects Limbic System Neuronal Activity and Gene Expression

  2022influential citation
• Expression of substance P, NPY and their Receptors Is Altered in Major Depression

  2022cites this paper
• Centrally acting cholecystokinin induces depressor circulatory effects in haemorrhage-shocked rats

  2021cites this paper
• Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

  2020cites this paper
• An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13

  2020cites this paper
• Serotonin and the neurobiology of anxious states

  2020cites this paper
• Excitation of Diverse Classes of Cholecystokinin Interneurons in the Basal Amygdala Facilitates Fear Extinction

  2019cites this paper
• Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide

  2019cites this paper
• Effects of High-Dose Genistein on the Hypothalamic RNA Profile and Intestinal Health of Female Chicks.

  2019cites this paper
• Enhanced susceptibility to stress and seizures in GAD65 deficient mice

  2018cites this paper
• Cholecystokinin (CCK) level is higher among first time suicide attempters than healthy controls, but is not associated with higher depression scores.

  2018cites this paper
• Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders

  2018cites this paper
• Endogenously Released Neuropeptide Y Suppresses Hippocampal Short-Term Facilitation and Is Impaired by Stress-Induced Anxiety

  2017cites this paper
• Animals, anxiety, and anxiety disorders: How to measure anxiety in rodents and why.

  2017cites this paper
• Neuropeptides : Active neuromodulators involved in the pathophysiology of suicidal behavior and major affective disorders

  2015cites this paper
• Pharmacological and methodological aspects of the separation-induced vocalization test in guinea pig pups; a systematic review and meta-analysis.

  2015cites this paper
• Exploring the association between a cholecystokinin promoter polymorphism (rs1799923) and posttraumatic stress disorder in combat veterans.

  2015cites this paper
• Neuropeptide S and mental health: A functional receptor gene variant and environment shaping traits and contributing to psychiatric disorders

  2014cites this paper
• Stress, Anxiety, and Cocaine Abuse

  2014cites this paper
• Receptors of peptides as therapeutic targets in epilepsy research.

  2014cites this paper
• Ärevushäirete psühhofarmakoloogia Schmiedebergist homseni

  2013cites this paper
• Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.

  2013cites this paper
• Neuropeptides in epilepsy.

  2013cites this paper
• Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.

  2013cites this paper
• The Role of Neuropeptides in Suicidal Behavior: A Systematic Review

  2013influential citation
• Enteroendocrine hormones - central effects on behavior.

  2013cites this paper
• Neuropeptides in Epilepsy

  2013cites this paper
• Current animal models of anxiety, anxiety disorders, and anxiolytic drugs

  2012cites this paper
• Cholecystokinin system genes: associations with panic and other psychiatric disorders.

  2012cites this paper
• Lateral Septal Regulation of Anxiety

  2012cites this paper
• Cholecystokinin: A multi‐functional molecular switch of neuronal circuits

  2011cites this paper
• Blockade of CRF1 and CCK2 receptors attenuated the elevated anxiety-like behavior induced by immobilization stress.

  2011cites this paper
• Cell-Type-Specific CCK2 Receptor Signaling Underlies the Cholecystokinin-Mediated Selective Excitation of Hippocampal Parvalbumin-Positive Fast-Spiking Basket Cells

  2011cites this paper
• Vanishing clinical psychopharmacology.

  2011cites this paper
• Micellar nanomedicine of human neuropeptide Y.

  2011cites this paper
• Topical cholecystokinin depresses itch-associated scratching behavior in mice.

  2011cites this paper
• Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.

  2011cites this paper
• Animal Models and Procedures for CNS Disorders

  2010cites this paper
• Biomarkers and Surrogate Markers in Drug Development

  2010cites this paper
• Relationship between respiratory, endocrine, and cognitive‐emotional factors in response to a pharmacological panicogen

  2010cites this paper
• In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

  2010cites this paper
• Naturally occurring variations in defensive burying behavior are associated with differences in vasopressin, oxytocin, and androgen receptors in the male rat.

  2009cites this paper
• Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

  2009cites this paper
• Functional Interactions between Endocannabinoid and CCK Neurotransmitter Systems May Be Critical for Extinction Learning

  2009cites this paper
• Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype.

  2009cites this paper
• Tachykinin receptors as therapeutic targets in stress-related disorders.

  2009cites this paper
• CaV1.3 L-type calcium channels modulate depression-like behavior in mice independent of deaf phenotype

  2009cites this paper
• Altered neuropeptide Y and neurokinin messenger RNA expression and receptor binding in stress-sensitised rats.

  2008cites this paper
• Neuropeptide Y Y2 receptor in health and disease

  2008cites this paper
• Reduced anxiety‐like and depression‐related behavior in neuropeptide Y Y4 receptor knockout mice

  2008cites this paper
• Stress-induced changes in primate prefrontal profiles of gene expression

  2007cites this paper
• Molecular Genetic Findings in Suicidal Behavior: What is Beyond the Serotonergic System?

  2007cites this paper
• Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala.

  2007cites this paper
• Brain regional neuropeptide changes resulting from social defeat.

  2007cites this paper
• Neuropeptides in anxiety and depression

  2006cites this paper